Work

Abstract 7325: Pharmacologic characterization of a highly specific and potent CLDN6xCD3 T cell engager (TCE), ARC101, for the treatment of CLDN6+ cancers

Year: 2025

Type: conference-abstract

Source: Cancer Research

DOI: 10.1158/1538-7445.am2025-7325

Authors: Sanjaya Singh, Danlin Yang, Joseph Erhardt, Theresa McDevitt, Scott R. Brodeur, Bridget Larkin, Cassandra Lowenstein, Desmond Lewis, Tabitha Soto, Brinda Shah

Language: English

Topic: Monoclonal and Polyclonal Antibodies Research

Subfield: Radiology, Nuclear Medicine and Imaging

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4409636136

Cites:

Cited by: 1

Related to: 10